Semler Scientific Inc. (SMLR)
| Market Cap | 213.50M |
| Revenue (ttm) | 53.86M |
| Net Income (ttm) | 15.71M |
| Shares Out | 6.79M |
| EPS (ttm) | 1.93 |
| PE Ratio | 16.28 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 74,487 |
| Open | 30.56 |
| Previous Close | 30.51 |
| Day's Range | 30.56 - 129.00 |
| 52-Week Range | 27.02 - 153.21 |
| Beta | 0.94 |
| Analysts | Buy |
| Price Target | 63.75 (+102.8%) |
| Earnings Date | Aug 1, 2022 |
About SMLR
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks... [Read more...]
Financial Performance
In 2021, SMLR's revenue was $53.03 million, an increase of 37.36% compared to the previous year's $38.60 million. Earnings were $17.22 million, an increase of 22.95%.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for SMLR stock is "Buy." The 12-month stock price forecast is 63.75, which is an increase of 102.83% from the latest price.
News
Why Semler Scientific Stock Is Sinking Today
The company missed analysts' estimates with its Q1 results.
Semler Scientific Inc. (SMLR) Lags Q1 Earnings and Revenue Estimates
Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of -19.61% and 5.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Semler Reports First Quarter 2022 Financial Results
2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million, an increase of $0.8 million, or 6%, compared to $13.2 million Net income was $3.4 million, or $0.50 per basi...
Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2, 2022
SANTA CLARA, Calif. , April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthca...
Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif. , April 7, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcar...
Semler Scientific's Board of Directors authorizes an up to $20.0 million stock repurchase program
SANTA CLARA, Calif. , March 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthca...
Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery
SANTA CLARA, Calif., March 1, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare...
Semler Reports Fourth Quarter and Year-to-Date 2021 Financial Results
SANTA CLARA, Calif., Feb. 28, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare...
Semler to Report Fourth Quarter and Year End 2021 Financial Results and Host Conference Call on February 28, 2022
SANTA CLARA, Calif., Feb. 17, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare...
4 Small Caps for Growth-Oriented Investors
Investors who are seeking opportunities among growth stocks could be interested in the following small-cap stocks, as they represent companies whose trailing 12-month net income per share has improved s...
Is Semler Scientific Stock Still a Buy After Its Earnings Miss?
The company reported slowing growth, but is there hope?
Semler Scientific Inc. (SMLR) Q3 Earnings and Revenues Miss Estimates
Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of -21.54% and -10.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the st...
Semler Reports Third Quarter and Year-to-Date 2021 Financial Results
SANTA CLARA, Calif., Nov. 1, 2021 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...
Semler to Report Third Quarter and First Nine Months of 2021 Financial Results and Host Conference Call on November 1...
SANTA CLARA, Calif., Oct. 22, 2021 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare...
This Top Small-Cap Just Became a Better Buy
With Semler moving to the Nasdaq, the company's strong business model will be more visible to investors.
Semler Scientific Inc. (SMLR) Surges 11.7%: Is This an Indication of Further Gains?
Semler Scientific Inc. (SMLR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...
Semler Scientific to Commence Trading on Nasdaq
SANTA CLARA, Calif., Sept. 27, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare...
Semler Scientific to Present at Upcoming Investor Conferences
SANTA CLARA, Calif., Aug. 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...
Semler Scientific Inc. (SMLR) Q2 Earnings Top Estimates
Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 36.07% and -1.51%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Semler Reports Second Quarter and First Half of 2021 Financial Results
SANTA CLARA, Calif., Aug. 2, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare p...
Semler Scientific Inc. (SMLR) Reports Next Week: Wall Street Expects Earnings Growth
Semler Scientific Inc. (SMLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021
SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...
Semler Scientific Inc. (SMLR) Soars 4.2%: Is Further Upside Left in the Stock?
Semler Scientific Inc. (SMLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the n...
What Makes Semler Scientific Inc. (SMLR) a New Buy Stock
Semler Scientific Inc. (SMLR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Semler to Participate in the Raymond James Human Health Innovation Conference
SANTA CLARA, Calif., June 10, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...